BIO-TECHNE Corp Finite-lived Intangible Assets Acquired
BIO-TECHNE Corp (TECH) reported Finite-lived Intangible Assets Acquired of $66.40 million for the 12-month period ending 2024-06-30, per its 10-K filed 2025-08-22.
Financial Statements › Notes › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2025-08-22
- BIO-TECHNE Corp finite-lived intangible assets acquired for the quarter ending 2024-06-30 was $0.00.
- BIO-TECHNE Corp finite-lived intangible assets acquired for the quarter ending 2024-03-31 was $0.00.
- BIO-TECHNE Corp finite-lived intangible assets acquired for the quarter ending 2023-12-31 was $0.00.
- BIO-TECHNE Corp finite-lived intangible assets acquired for the quarter ending 2023-09-30 was $66.40M, a 12.17% decline year-over-year.
- BIO-TECHNE Corp finite-lived intangible assets acquired for fiscal 2024 was $66.40M, a 12.17% decline from fiscal 2023.
- BIO-TECHNE Corp finite-lived intangible assets acquired for fiscal 2023 was $75.60M.
- BIO-TECHNE Corp finite-lived intangible assets acquired for fiscal 2021 was $153.31M.
- BIO-TECHNE Corp finite-lived intangible assets acquired for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Finite-lived Intangible Assets Acquired 3 month | Finite-lived Intangible Assets Acquired 6 month | Finite-lived Intangible Assets Acquired 9 month | Finite-lived Intangible Assets Acquired 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $0.00 derived: sum of 2 quarters · filed 2025-08-22 | $0.00 derived: sum of 3 quarters · filed 2025-08-22 | $66.40M 10-K · filed 2025-08-22 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | $0.00 derived: sum of 2 quarters · filed 2024-05-06 | $66.40M 10-Q · filed 2024-05-06 | $66.40M derived: sum of 4 quarters · filed 2024-08-22 |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $66.40M 10-Q · filed 2024-02-07 | $66.40M derived: sum of 3 quarters · filed 2024-08-22 | $66.40M derived: sum of 4 quarters · filed 2024-08-22 |
| 2023-09-30 | $66.40M 10-Q · filed 2023-11-07 | $66.40M derived: sum of 2 quarters · filed 2024-08-22 | $66.40M derived: sum of 3 quarters · filed 2024-08-22 | $66.40M derived: sum of 4 quarters · filed 2024-08-22 |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $0.00 derived: sum of 2 quarters · filed 2024-08-22 | $0.00 derived: sum of 3 quarters · filed 2024-08-22 | $75.60M 10-K · filed 2024-08-22 |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $0.00 derived: sum of 2 quarters · filed 2023-05-08 | $75.60M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $75.60M 10-Q · filed 2023-02-07 | ||
| 2022-09-30 | $75.60M 10-Q · filed 2022-11-07 | |||
| 2021-12-31 | $0.00 10-Q · filed 2022-02-07 | $0.00 derived: sum of 2 quarters · filed 2022-02-07 | $144.39M derived: sum of 3 quarters · filed 2022-08-24 | $144.39M derived: sum of 4 quarters · filed 2022-08-24 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-08 | $144.39M derived: sum of 2 quarters · filed 2022-08-24 | $144.39M derived: sum of 3 quarters · filed 2022-08-24 | $153.31M derived: sum of 4 quarters · filed 2022-08-24 |
| 2021-06-30 | $144.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $144.39M derived: sum of 2 quarters · filed 2022-08-24 | $153.31M derived: sum of 3 quarters · filed 2022-08-24 | $153.31M 10-K · filed 2022-08-24 |
| 2021-03-31 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | $8.92M derived: sum of 2 quarters · filed 2021-05-07 | $8.92M 10-Q · filed 2021-05-07 | $8.92M derived: sum of 4 quarters · filed 2021-08-25 |
| 2020-12-31 | $8.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $8.92M 10-Q · filed 2021-02-08 | $8.92M derived: sum of 3 quarters · filed 2021-08-25 | $8.92M derived: sum of 4 quarters · filed 2021-08-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-08-25 | $0.00 derived: sum of 3 quarters · filed 2021-08-25 | $0.00 derived: sum of 4 quarters · filed 2021-08-25 |
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $0.00 derived: sum of 2 quarters · filed 2021-08-25 | $0.00 derived: sum of 3 quarters · filed 2021-08-25 | $0.00 10-K · filed 2021-08-25 |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2020-05-11 | $0.00 10-Q · filed 2020-05-11 | $14.46M derived: sum of 4 quarters · filed 2020-08-26 |
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $0.00 10-Q · filed 2020-02-06 | $14.46M derived: sum of 3 quarters · filed 2020-08-26 | -$1.44M derived: sum of 4 quarters · filed 2020-08-26 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 | $14.46M derived: sum of 2 quarters · filed 2020-08-26 | -$1.44M derived: sum of 3 quarters · filed 2020-08-26 | -$8.04M derived: sum of 4 quarters · filed 2020-08-26 |
| 2019-06-30 | $14.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | -$1.44M derived: sum of 2 quarters · filed 2020-08-26 | -$8.04M derived: sum of 3 quarters · filed 2020-08-26 | $191.96M 10-K · filed 2020-08-26 |
| 2019-03-31 | -$15.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | -$22.50M derived: sum of 2 quarters · filed 2019-05-07 | $177.50M 10-Q · filed 2019-05-07 | $194.88M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-12-31 | -$6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $193.40M 10-Q · filed 2019-02-07 | $210.78M derived: sum of 3 quarters · filed 2019-11-06 | $228.55M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-09-30 | $200.00M 10-Q · filed 2018-11-07 | $217.38M derived: sum of 2 quarters · filed 2019-11-06 | $235.15M derived: sum of 3 quarters · filed 2019-11-06 | $233.57M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $17.38M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $35.15M derived: sum of 2 quarters · filed 2019-11-06 | $33.57M derived: sum of 3 quarters · filed 2019-11-06 | $40.67M 10-K/A · filed 2019-11-06 |
| 2018-03-31 | $17.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $16.19M derived: sum of 2 quarters · filed 2018-05-09 | $23.29M 10-Q · filed 2018-05-09 | $292.00K derived: sum of 4 quarters · filed 2018-08-27 |
| 2017-12-31 | -$1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $5.52M 10-Q · filed 2018-02-08 | -$17.48M derived: sum of 3 quarters · filed 2018-08-27 | -$17.48M derived: sum of 4 quarters · filed 2018-08-27 |
| 2017-09-30 | $7.10M 10-Q · filed 2017-11-09 | -$15.90M derived: sum of 2 quarters · filed 2018-08-27 | -$15.90M derived: sum of 3 quarters · filed 2018-08-27 | -$14.80M derived: sum of 4 quarters · filed 2018-08-27 |
| 2017-06-30 | -$23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | -$23.00M derived: sum of 2 quarters · filed 2018-08-27 | -$21.90M derived: sum of 3 quarters · filed 2018-08-27 | $185.87M 10-K · filed 2018-08-27 |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | $1.10M derived: sum of 2 quarters · filed 2017-05-10 | $208.87M 10-Q · filed 2017-05-10 | $213.54M derived: sum of 4 quarters · filed 2017-09-07 |
| 2016-12-31 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $208.87M 10-Q · filed 2017-02-09 | $213.54M derived: sum of 3 quarters · filed 2017-09-07 | $216.04M derived: sum of 4 quarters · filed 2017-09-07 |
| 2016-09-30 | $207.77M 10-Q · filed 2016-11-09 | $212.44M derived: sum of 2 quarters · filed 2017-09-07 | $214.94M derived: sum of 3 quarters · filed 2017-09-07 | $215.17M derived: sum of 4 quarters · filed 2017-09-07 |
| 2016-06-30 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $7.17M derived: sum of 2 quarters · filed 2017-09-07 | $7.40M derived: sum of 3 quarters · filed 2017-09-07 | $53.50M 10-K · filed 2017-09-07 |
| 2016-03-31 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $2.73M derived: sum of 2 quarters · filed 2016-05-10 | $48.83M 10-Q · filed 2016-05-10 | $48.52M derived: sum of 4 quarters · filed 2016-08-29 |
| 2015-12-31 | $225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | $46.33M 10-Q · filed 2016-02-09 | $46.02M derived: sum of 3 quarters · filed 2016-08-29 | $44.33M derived: sum of 4 quarters · filed 2016-08-29 |
| 2015-09-30 | $46.10M 10-Q · filed 2015-11-09 | $45.80M derived: sum of 2 quarters · filed 2016-08-29 | $44.10M derived: sum of 3 quarters · filed 2016-08-29 | $63.00M derived: sum of 4 quarters · filed 2016-08-29 |
| 2015-06-30 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | -$2.00M derived: sum of 2 quarters · filed 2016-08-29 | $16.90M derived: sum of 3 quarters · filed 2016-08-29 | $222.71M 10-K · filed 2016-08-29 |
| 2015-03-31 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | $17.20M derived: sum of 2 quarters · filed 2015-05-11 | $223.01M 10-Q · filed 2015-05-11 | $237.63M derived: sum of 4 quarters · filed 2015-08-31 |
| 2014-12-31 | $18.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09 | $224.71M 10-Q · filed 2015-02-09 | $239.33M derived: sum of 3 quarters · filed 2015-08-31 | $239.33M derived: sum of 4 quarters · filed 2015-08-31 |
| 2014-09-30 | $205.81M 10-Q · filed 2014-11-10 | $220.43M derived: sum of 2 quarters · filed 2015-08-31 | $220.43M derived: sum of 3 quarters · filed 2015-08-31 | $220.43M derived: sum of 4 quarters · filed 2015-08-31 |
| 2014-06-30 | $14.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $14.62M derived: sum of 2 quarters · filed 2015-08-31 | $14.62M derived: sum of 3 quarters · filed 2015-08-31 | $75.12M 10-K · filed 2015-08-31 |
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2014-05-12 | $60.50M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04 | $60.50M 10-Q · filed 2014-02-04 | ||
| 2013-09-30 | $60.50M 10-Q · filed 2013-11-12 | |||
| 2013-06-30 | $0.00 10-K · filed 2014-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |